Cargando…
Trough concentration may not be a good target for polymyxin B therapeutic drug monitoring
Autores principales: | Zhao, Yuhua, Chen, Huadong, Yu, Zhenwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9878747/ https://www.ncbi.nlm.nih.gov/pubmed/36698153 http://dx.doi.org/10.1186/s13054-023-04326-8 |
Ejemplares similares
-
Variability of Isavuconazole Trough Concentrations during Longitudinal Therapeutic Drug Monitoring
por: Bolcato, Léa, et al.
Publicado: (2022) -
Respiratory arrest associated with polymyxin B in a lung transplant patient
por: Chen, Wen-Hui, et al.
Publicado: (2020) -
Relationship between raltegravir trough plasma concentration and
virologic response and the impact of therapeutic drug monitoring during
pregnancy
por: Carvalho, Sabrina, et al.
Publicado: (2022) -
Effectiveness, nephrotoxicity, and therapeutic drug monitoring of polymyxin B in nosocomial pneumonia among critically ill patients
por: Ye, Qinghua, et al.
Publicado: (2022) -
Correlation between the drug concentration of polymyxin B and polymyxin B‐associated acute kidney injury in critically ill patients: A prospective study
por: Xu, Ying, et al.
Publicado: (2022)